229 related articles for article (PubMed ID: 21274874)
21. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
[TBL] [Abstract][Full Text] [Related]
22. Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis.
Semple PL; Binder AB; Davids M; Maredza A; van Zyl-Smit RN; Dheda K
Am J Respir Crit Care Med; 2013 Jun; 187(11):1249-58. PubMed ID: 23590266
[TBL] [Abstract][Full Text] [Related]
23. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.
Longhi MS; Hussain MJ; Mitry RR; Arora SK; Mieli-Vergani G; Vergani D; Ma Y
J Immunol; 2006 Apr; 176(7):4484-91. PubMed ID: 16547287
[TBL] [Abstract][Full Text] [Related]
24. Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis.
Liberal R; Grant CR; Yuksel M; Graham J; Kalbasi A; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2017 Nov; 66(5):1570-1584. PubMed ID: 28597951
[TBL] [Abstract][Full Text] [Related]
25. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
Longhi MS; Ma Y; Bogdanos DP; Cheeseman P; Mieli-Vergani G; Vergani D
J Hepatol; 2004 Jul; 41(1):31-7. PubMed ID: 15246204
[TBL] [Abstract][Full Text] [Related]
26. Alterations in regulatory T-cells: rediscovered pathways in immunotoxicology.
Corsini E; Oukka M; Pieters R; Kerkvliet NI; Ponce R; Germolec DR
J Immunotoxicol; 2011; 8(4):251-7. PubMed ID: 21848365
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.
Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U
J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878
[TBL] [Abstract][Full Text] [Related]
28. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
Klein R; Zanger UM; Berg T; Hopf U; Berg PA
Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
[TBL] [Abstract][Full Text] [Related]
29. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
[TBL] [Abstract][Full Text] [Related]
30. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.
Löhr HF; Schlaak JF; Lohse AW; Böcher WO; Arenz M; Gerken G; Meyer Zum Büschenfelde KH
Hepatology; 1996 Dec; 24(6):1416-21. PubMed ID: 8938173
[TBL] [Abstract][Full Text] [Related]
31. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.
Liu T; Soong L; Liu G; König R; Chopra AK
Biol Direct; 2009 Oct; 4():40. PubMed ID: 19852824
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
Kerkar N; Choudhuri K; Ma Y; Mahmoud A; Bogdanos DP; Muratori L; Bianchi F; Williams R; Mieli-Vergani G; Vergani D
J Immunol; 2003 Feb; 170(3):1481-9. PubMed ID: 12538711
[TBL] [Abstract][Full Text] [Related]
33. Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells.
Longhi MS; Mitry RR; Samyn M; Scalori A; Hussain MJ; Quaglia A; Mieli-Vergani G; Ma Y; Vergani D
Hepatology; 2009 Jul; 50(1):130-42. PubMed ID: 19437492
[TBL] [Abstract][Full Text] [Related]
34. The role of regulatory T cell (Treg) subsets in gestational diabetes mellitus.
Schober L; Radnai D; Spratte J; Kisielewicz A; Schmitt E; Mahnke K; Fluhr H; Uhlmann L; Sohn C; Steinborn A
Clin Exp Immunol; 2014 Jul; 177(1):76-85. PubMed ID: 24547967
[TBL] [Abstract][Full Text] [Related]
35. CD4(+) CD25(+) FoxP3(+) regulatory T cells suppress cytotoxicity of CD8(+) effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level.
Göbel K; Bittner S; Melzer N; Pankratz S; Dreykluft A; Schuhmann MK; Meuth SG; Wiendl H
J Neuroinflammation; 2012 Feb; 9():41. PubMed ID: 22373353
[TBL] [Abstract][Full Text] [Related]
36. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
[TBL] [Abstract][Full Text] [Related]
37. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.
Djilali-Saiah I; Fakhfakh A; Louafi H; Caillat-Zucman S; Debray D; Alvarez F
J Hepatol; 2006 Dec; 45(6):844-50. PubMed ID: 17050030
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.
Ventura C; Bisceglia H; Girerd-Chambaz Y; Burdin N; Chaux P
J Clin Immunol; 2012 Dec; 32(6):1305-16. PubMed ID: 22797815
[TBL] [Abstract][Full Text] [Related]
39. Myeloid-derived suppressor cells suppress CD4⁺ and CD8⁺ T cell responses in autoimmune hepatitis.
Li H; Dai F; Peng Q; Gan H; Zheng J; Xia Y; Zhang W
Mol Med Rep; 2015 Sep; 12(3):3667-3673. PubMed ID: 25998831
[TBL] [Abstract][Full Text] [Related]
40. Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells.
Fu BM; He XS; Yu S; Hu AB; Ma Y; Wu LW; Tam NL; Huang JF
Exp Clin Transplant; 2009 Sep; 7(3):149-56. PubMed ID: 19715524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
